FDA advisers consider changing COVID vaccine to target latest omicron strain The COVID-19 vaccines are on track for a big recipe change this fall The Independent UK · Jun 15, 2023
Down to Earth: Is this lab-grown fish the future of seafood? We put it to the taste test In this week’s newsletter: A California company thinks its cell-cultured tuna may be the way to enioy fish – without the fish The Guardian - UK · Jun 15, 2023
Does Medicare pay for Alzheimer's drugs? The answer is complicated and changing There are no drugs or treatments to cure Alzheimer’s disease, but emerging drugs may slow disease progression. Fortune · Jun 15, 2023
Explained | What is transcranial magnetic stimulation? On May 15, a study by Stanford University researchers reported some evidence that in people without depression, a part of the brain called the anterior insula sends signals to another part called the anterior cingulate cortex, whereas in people with depression, the signal goes the other way. According to the… The Hindu · Jun 15, 2023
What is ‘Ozempic face’? Doctors warn about facial ageing side effect of diabetes medications “Weight loss may turn back your biological age, but it tends to turn your facial clock forward,” one dermatologist says The Independent UK · Jun 14, 2023
3 Biotech Stocks With Great Value The global demand for healthcare and biotech products continues to grow, owing to factors such as increasing chronic diseases and a greater focus on personalized medicine. Therefore, it might be wise to check out fundamentally sound biotech stocks BioMarin Pharmaceutical (BMRN), Exelixis, Inc. (EXEL), and Theratechnologies (THTX), currently trading at… StockNews.com · Jun 14, 2023
Recall issued over frozen strawberry products linked to hepatitis A outbreak The outbreak linked to frozen organic strawberries imported from Baja California, Mexico, The Independent UK · Jun 14, 2023
Frozen strawberries recall: Costco, Walmart products recalled for Hepatitis A risk Multiple brands of frozen strawberry products have been linked to a Hepatitis A outbreak. Axios · Jun 14, 2023
FDA issues recall over frozen strawberry products linked to hepatitis A outbreak The outbreak linked to frozen organic strawberries imported from Baja California, Mexico, The Independent UK · Jun 14, 2023
Best Constant Glucose Monitor for Apple devices What gets measured gets managed, and constant glucose monitors make managing diabetes far simpler. iMore · Jun 14, 2023
Should You Buy Into Pfizer (PFE) Today? Despite a slowdown of Covid-19 vaccine sales in the last reported quarter, biopharmaceutical giant Pfizer (PFE) is positioned to deliver robust growth this year and beyond, thanks to the strength of its in-line products and expected near-term launches and revenue distribution from the recent acquisition. So, let’s find out if… StockNews.com · Jun 13, 2023
Amy Schumer says she stopped taking Ozempic because of side-effects Ozempic is a once-weekly injection used for the treatment of type 2 diabetes, though some of its side effects include weight loss The Independent UK · Jun 13, 2023
Amy Schumer says she stopped taking Ozempic because of side-effects Ozempic is a once-weekly injection used for the treatment of type 2 diabetes, though some of its side effects include weight loss The Independent UK · Jun 12, 2023
The Pixel Watch finally picks up a health feature it should have had from the get-go The Pixel Watch's SpO2 sensor, which has been dormant since launch, has been spotted recording data for some users. Android Central · Jun 12, 2023
Inverse · Jun 10, 2023 Weight-Loss Drugs Like Ozempic Are Powerful, but a Simple Health Fix May Be Better In the past five years, several new drugs have been brought to market that could lead to a profound, if not revolutionary, change in how healthcare providers – and the public – view weight loss.
The Guardian - US · Jun 10, 2023 FDA advisers say new Alzheimer’s drug lecanemab slows cognitive decline Panel’s opinion could pave way for full regulatory approval next month for treatment of disease that affects 6.5m Americans
The Independent UK · Jun 9, 2023 Amy Schumer reveals she tried Ozempic while calling out celebrities for not being ‘real’ about weight loss Ozempic is a once-weekly injection used for the treatment of type 2 diabetes, though some of its side effects include weight loss
Axios · Jun 9, 2023 Experimental Alzheimer's drug endorsed for full approval by FDA advisers Leqembi could become the first treatment of its kind to receive traditional approval from the FDA.
The Independent UK · Jun 9, 2023 Alzheimer's drug gets FDA panel's backing, setting the stage for broader use U.S. health advisers are backing the full approval of an Alzheimer's drug that received preliminary approval last year
WEKU · Jun 8, 2023 FDA advisers endorse new RSV antibody drug for babies A panel of experts to the Food and Drug Administration has recommended the agency approve a long-acting antibody drug that can protect infants from the seasonal virus, RSV.
The Guardian - UK · Jun 8, 2023 Vote on plans to bar MPs accused of sexual or violent offences delayed Staff will be left at risk if proposals to ban members under police investigation from Westminster estate dropped, unions say
Marie Claire · Jun 8, 2023 Inside the World of Ambitious Aging Biohacking promises to make you feel and look decades younger. So what's the catch?
StockNews.com · Jun 7, 2023 3 Undervalued Pharma Stocks Worth Buying With the growing prevalence of chronic diseases, the adoption of advanced digital technologies, and new drug discoveries, the pharmaceutical industry is set to witness significant growth this year and beyond. Thus, it could be wise to invest in quality pharma stocks Ipsen (IPSEY), Supernus (SUPN), and Kamada (KMDA), which are…
Salon · Jun 6, 2023 The anti-vaxxer threat keeps spreading With vaccines on the horizon, RSV could finally be preventable. But anti-vax misinfo could get in the way
WEKU · Jun 6, 2023 AI in medicine needs to be carefully deployed to counter bias – and not entrench it Powerful new artificial intelligence tools can perpetuate long-standing racial inequities if they are not designed very carefully. Researchers and regulators are taking note, but perils are vast.